Investigating high circulating IGF-1 as a risk factor for development of prostate cancer
Prostate cancer is the commonest cancer in UK men. Prostate cancers upregulate type 1 insulin-like growth factor receptor (IGF-1R), and men with high serum IGF-1 have an increased risk of prostate cancer and of dying from prostate cancer. Subjects with low circulating IGF-1 are strongly protected fr...
Main Author: | Nandakumar, AM |
---|---|
Other Authors: | MacAulay, V |
Format: | Thesis |
Language: | English |
Published: |
2022
|
Subjects: |
Similar Items
-
Investigating the biology of nuclear IGF-1R in prostate cancer
by: Mills, JV
Published: (2021) -
The role of IGF-1R signaling in the DNA damage response of prostate cancer
by: Lodhia, K
Published: (2013) -
Investigation of the effects of IGF-1 receptor blockade on chemoresistance of advanced melanoma
by: Ramcharan, R, et al.
Published: (2014) -
The evaluation of the IGF-1R as a proposed biomarker for DNA damaging cancer therapies
by: Worrall, R
Published: (2014) -
Investigations on anti-IGF-1R therapy response in a colorectal cancer cell line panel
by: Puschhof, J
Published: (2016)